{
    "relation": [
        [
            "Treatments",
            "thapsigargin",
            ""
        ],
        [
            "Referenced Treatments",
            "",
            "thapsigargin"
        ],
        [
            "Manipulated Protein",
            "",
            "PKR (mouse)"
        ],
        [
            "Referenced Protein",
            "",
            ""
        ],
        [
            "Effect",
            "increase",
            "increase"
        ],
        [
            "Notes",
            "",
            "PKR -/- decrreases"
        ]
    ],
    "pageTitle": "Curated Information",
    "title": "",
    "url": "http://www.phosphosite.org/curatedInfoAction.do?record=14151805",
    "hasHeader": true,
    "headerPosition": "FIRST_ROW",
    "tableType": "RELATION",
    "tableNum": 25,
    "s3Link": "common-crawl/crawl-data/CC-MAIN-2015-32/segments/1438042988511.77/warc/CC-MAIN-20150728002308-00106-ip-10-236-191-2.ec2.internal.warc.gz",
    "recordEndOffset": 651132006,
    "recordOffset": 651123804,
    "tableOrientation": "HORIZONTAL",
    "textBeforeTable": "\u00a0Treatments, proteins and their effect on site modification:\u00a0 Upstream Regulation \u00a0Species studied:\u00a0 mouse \u00a0Cellular systems studied:\u00a0 primary cells \u00a0Relevant cell lines - cell types - tissues:\u00a0 MEF (fibroblast) [PKR (mouse), homozygous knockout] \u00a0Disease tissue studied:\u00a0 type 2 diabetes \u00a0Methods used to characterize site in vivo:\u00a0 phospho-antibody, western blotting Characterization Akt1\u00a0(human): S473\u2011p, Akt1\u00a0(mouse): S473\u2011p, Akt1\u00a0(rat): S473\u2011p, Akt1\u00a0(fruit\u00a0fly): S586\u2011p, Akt1\u00a0(cow): S473\u2011p Orthologous residues \u25b2 S473-p\u00a0-\u00a0Akt1 (mouse) Only sites from this record are displayed on this page. Click on the protein name to",
    "textAfterTable": "S52-p\u00a0-\u00a0eIF2-alpha (mouse) \u25b2 Orthologous residues eIF2\u2011alpha\u00a0(human): S52\u2011p, eIF2\u2011alpha\u00a0(mouse): S52\u2011p, eIF2\u2011alpha\u00a0(rat): S52\u2011p, eIF2\u2011alpha\u00a0(rabbit): S51\u2011p, eIF2\u2011alpha\u00a0(fruit\u00a0fly): S51\u2011p Characterization \u00a0Methods used to characterize site in vivo:\u00a0 phospho-antibody, western blotting \u00a0Disease tissue studied:\u00a0 type 2 diabetes \u00a0Relevant cell lines - cell types - tissues:\u00a0 MEF (fibroblast) [PKR (mouse), homozygous knockout] \u00a0Cellular systems studied:\u00a0 primary cells \u00a0Species studied:\u00a0 mouse Upstream Regulation \u00a0Treatments, proteins and their effect on site modification:\u00a0 Treatments Referenced Treatments Manipulated Protein",
    "hasKeyColumn": true,
    "keyColumnIndex": 0,
    "headerRowIndex": 0
}